Description: Mayne Pharma Group Limited develops and manufactures branded and generic products, which it distributes directly or through distribution partners and also provides contract development and manufacturing services.
Home Page: www.maynepharma.com
1538 Main North Road
Salisbury South,
SA
5106
Australia
Phone:
61 8 8209 2666
Officers
| Name | Title |
|---|---|
| Mr. Shawn Patrick O'Brien B.Sc | CEO, MD & Director |
| Mr. Aaron Gray | Chief Financial Officer |
| Ms. Lisa Pendlebury | VP of Investor Relations & Communications |
| Ms. Kimberly Parker J.D. | Exec. VP & Gen. Counsel |
| Mr. Brant Schofield | Exec. VP of Corp. Devel. |
| Dr. Andrew O. Herdman Ph.D. | VP of Group HR |
| Mr. Stefan J. Cross | Pres of International Operations |
| Mr. Daniel Moore | Exec. VP of Specialty Products & Patient Solutions |
| Mr. Gerard G. Nahum M.D. | Chief Medical Officer |
| Mr. Hemanshu N. Pandya | Sr. VP & Head of Generic Product Division |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 277.7778 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7261 |
| Price-to-Sales TTM: | 0.6516 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 0 |